# Balchem Corporation (BCPC) fundamentals

Data as of 2026-09-08. NASDAQ, United States. Sector: Basic Materials / Chemicals. Price $171.61, market value $5.5 billion.

## Valuation
- **P/E (trailing): 33.8×** (5-yr avg 42.1×, 3-yr avg 39.1×). Balchem Corporation trades at 33.8× trailing earnings, close to its own five-year average of 42.1×. The Basic Materials median in the September 2026 study was 19.0×. Forward P/E is 27.4×, lower than trailing, so analysts expect earnings to grow.
- **PEG: 1.31**. A PEG of 1.31 is in the range usually read as fairly priced for its growth.
- **Price / sales: 5.0×**. Each dollar of revenue is priced at 5.0×.
- **Price / book: 4.2×**. The shares trade at 4.2× book value; book value is a meaningful part of the valuation.
- **EV / EBITDA: 20.6×**. Enterprise value is 20.6× operating earnings before depreciation, the multiple that ignores how the company is financed; above 20× is demanding.
- **Earnings yield: 3.0%**. The inverse of the P/E: 3.0% of the price is earned each year.

## Profitability
- **Gross margin: 36.3%**. Balchem Corporation keeps 36.3% of revenue after the direct cost of what it sells.
- **Operating margin: 20.4%**. 20.4% of revenue is left after running the business, a healthy level in most sectors.
- **Net margin: 14.9%**. 14.9% of each dollar of sales reaches the bottom line.
- **Return on equity: 12.3%**. 12.3% on shareholders' equity is solid.
- **Return on invested capital: 13.1%**. Return on all capital, debt included, is 13.1%.
- **Return on assets: 9.8%**. Each dollar of assets produces 9.8% of profit.

## Growth
- **Revenue growth (1 yr): 8.8%** (3-yr 3.2%/yr, 5-yr 8.1%/yr). Revenue grew 8.8% over the last year, against 8.1% a year compounded over five years.
- **EPS growth (1 yr): 20.9%** (3-yr 13.5%/yr, 5-yr 12.8%/yr). Earnings per share rose 20.9%, faster than revenue, so margins expanded or the share count shrank.

## Financial health
- **Debt to equity: 0.12**. Debt is 0.12 times equity: a conservative balance sheet.
- **Net debt / EBITDA: 0.3×**. It would take 0.3 years of operating earnings to repay net borrowings, within the comfortable range.
- **Current ratio: 2.07** (quick 2.07). Current assets cover the next year's liabilities 2.07 times.
- **Altman Z-score: 9.86**. A Z-score of 9.86 places the company in the safe zone for bankruptcy risk.
- **Piotroski F-score: 9/9**. 9 of 9 fundamental checks pass: strong and improving financials.

## Dividends
- **Dividend yield: 0.56%** ($0.96 per share, trailing). Balchem Corporation yields 0.56%, a modest yield more typical of a growth-oriented payer.
- **Payout ratio: 18%**. 18% of earnings goes out as dividends, leaving room to keep raising it.
- **Consecutive years of increases: 26**. 26 straight years of increases (the data covers 26 years, so this may be longer): a record very few companies hold.
- **Dividend growth (5 yr): 10.6%/yr** (1-yr 10.3%). The dividend has compounded at 10.6% a year over five years, doubling roughly every 7 years at that pace.

## Analyst view
- **Analyst consensus: buy** (4 analysts). 4 analysts cover Balchem Corporation; the consensus is buy, with an average price target of $209.25 (+22% from the current price). Analyst opinion is shown for context; it is not part of the Fundamental Score.

## Price and momentum
- **Total return (1 yr): 7.0%** (YTD 11.9%, 3-mo 7.3%). The shares are up 7.0% over twelve months including dividends.
- **From 52-week high: -6.7%** (23.3% above the low). Trading 7% below its 52-week high.
- **200-day average: above**. The price sits above its 200-day moving average, the usual definition of an uptrend.
- **RSI (14-day): 43**. An RSI of 43 is neutral.
- **Beta (1 yr): 0.19** (volatility 22%). Beta of 0.19 against the S&P 500: the shares move much less than the market.

Live score and charts: https://foliofundamentals.com/analyzer?s=BCPC · Page: https://foliofundamentals.com/stocks/bcpc

Not investment advice.